Cash Flow Catalyst Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
216.00
94.00
104.00
52.00
41.00
33.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
30.00
-37.00
13.00
5.00
-4.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
239.00
143.00
116.00
60.00
45.00
34.00
Cash Flow from Investing Activities
0.00
-293.00
9.00
-11.00
-5.00
37.00
Cash Flow from Financing Activities
140.00
-10.00
1.00
-8.00
0.00
1.00
Net Cash Inflow / Outflow
379.00
-160.00
126.00
41.00
40.00
72.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Catalyst Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
216.263
717.969
-501.00
-69.88%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
30.914
-19.768
49.00
256.38%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
239.808
-389.841
628.00
161.51%
Cash Flow from Investing Activities
-0.556
363.441
-363.00
-100.15%
Cash Flow from Financing Activities
140.665
14.442
126.00
874.00%
Net Cash Inflow / Outflow
379.917
-11.958
390.00
3277.09%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 67.00% vs 23.74% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
239.81
143.60
67.00%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
